{
    "2020-11-01": [
        [
            {
                "time": "2023-11-01",
                "original_text": "公告精选丨蚂蚁集团中签号出炉；傲农生物10月生猪销售量同比增逾4倍",
                "features": {
                    "keywords": [
                        "蚂蚁集团",
                        "中签号",
                        "傲农生物",
                        "生猪销售",
                        "同比增长"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "农业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-11-01",
                "original_text": "复星集团郭广昌：制造业是温州的基础 创新应成为未来发展核心",
                "features": {
                    "keywords": [
                        "复星集团",
                        "郭广昌",
                        "制造业",
                        "创新"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "制造业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-11-01",
                "original_text": "莎普爱思滴眼液，因一致性评价问题或将停产；国采第三批陆续执行；77药品纳入临床急需境外新药名单｜云端周报 经营问题",
                "features": {
                    "keywords": [
                        "莎普爱思",
                        "一致性评价",
                        "停产",
                        "国采",
                        "临床急需",
                        "境外新药"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-11-01",
                "original_text": "复星医药(600196.SH)：就与Lilly签署许可协议现对主要付款安排作补充",
                "features": {
                    "keywords": [
                        "复星医药",
                        "Lilly",
                        "许可协议",
                        "付款安排"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-11-01",
                "original_text": "128股获买入评级最新: 中航机电",
                "features": {
                    "keywords": [
                        "买入评级",
                        "中航机电"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "航空制造"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-11-01",
                "original_text": "复星医药：控股子公司复创医药与Lilly签署许可协议",
                "features": {
                    "keywords": [
                        "复星医药",
                        "复创医药",
                        "Lilly",
                        "许可协议"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-11-01",
                "original_text": "医药生物行业专题研究：从壁垒出发寻找医美领域的确定性机遇",
                "features": {
                    "keywords": [
                        "医药生物",
                        "医美",
                        "壁垒",
                        "机遇"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医美"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-11-01",
                "original_text": "医药行业每周药闻：医药零售板块2020年三季报业绩总结：抓住景气度提升明确的优质赛道",
                "features": {
                    "keywords": [
                        "医药零售",
                        "三季报",
                        "业绩总结",
                        "景气度提升"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药零售"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-11-01",
                "original_text": "热门融资标的股票分析",
                "features": {
                    "keywords": [
                        "融资",
                        "标的股票",
                        "分析"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-11-01",
                "original_text": "复星医药(600196)：业绩符合预期 创新药物成功出海！",
                "features": {
                    "keywords": [
                        "复星医药",
                        "业绩",
                        "创新药物",
                        "出海"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}